Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant in histamine-refractory chronic pruritus
2013-001601-85Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic pruritus (CP) and prurigo nodularis (PN) comparing Aprepitant with Placebo (2 arms). Started Nov 2013; status: completed.
02
Drugs
aprepitant
03
Conditions
chronic pruritus (CP)prurigo nodularis (PN)
Beyond the preview
Go deeper on 2013-001601-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001601-85.